Your browser doesn't support javascript.
loading
Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated TERT promoter mutation.
Wijnenga, Maarten M J; Maas, Sybren L N; van Dis, Vera; Tesileanu, C Mircea S; Kros, Johan M; Dirven, Linda; Hazelbag, Hans M; Dubbink, Hendrikus J; Vincent, Arnaud J P E; French, Pim J; van den Bent, Martin J.
Afiliación
  • Wijnenga MMJ; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Maas SLN; Department of Pathology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van Dis V; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Tesileanu CMS; Department of Pathology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Kros JM; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Dirven L; Department of Pathology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Hazelbag HM; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
  • Dubbink HJ; Department of Pathology, Medical Center Haaglanden, The Hague, The Netherlands.
  • Vincent AJPE; Department of Pathology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • French PJ; Department of Neurosurgery, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • van den Bent MJ; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Neurooncol Adv ; 5(1): vdad075, 2023.
Article en En | MEDLINE | ID: mdl-37441086